ARWR-10K-20160930

Company

ARROWHEAD PHARMACEUTICALS, INC.

Filed

December 14, 2016

Period of Report

September 30, 2016

Accession Number

0001564590-16-030217

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →